Progenity Revenue and Competitors
Estimated Revenue & Valuation
- Progenity's estimated annual revenue is currently $45M per year.
- Progenity received $125.0M in venture funding in November 2017.
- Progenity's estimated revenue per employee is $293,791
- Progenity's total funding is $248.5M.
Employee Data
- Progenity has 153 Employees.
- Progenity grew their employee count by -70% last year.
Progenity Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $564.8M | 2844 | 3% | $404.1M | $6.4B |
#2 | $14.2M | 62 | 9% | N/A | N/A |
What Is Progenity?
Progenity helps patients and their families Prepare for Life, with medically relevant health information starting before conception, through pregnancy, childhood, and adulthood. Using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages.
keywords:Biotechnology,Healthcare,Medical Diagnostics
$248.5M
Total Funding
153
Number of Employees
$45M
Revenue (est)
-70%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Progenity News
Progenity Appoints Paul Shabram to Lead Technical Operations of the Company's Ingestible Drug/Device Platforms. Progenity, Inc. Mon, April 25,...
Progenity, Inc, a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company...
Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics and is developing a...
By Chris Wack Progenity Inc. said it has received more than $44 million in warrant exercises since August. The biotechnology company said that as a result of previously issued warrants being exercised and other capital-raising transactions, it believes its current liquidity position provides s ...
Patent number: 11134889 Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor. Type: Grant Filed: December 14, 2017 Date of Patent: October 5, 2021 Assignee: Progenity, Inc. Inventors: Mitchell Lawrence Jones ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.7M | 153 | 18% | $791.4M |
#2 | $38.4M | 153 | -24% | N/A |
#3 | $20.2M | 153 | 7% | N/A |
#4 | $29.8M | 154 | 15% | $134.1M |
#5 | $45.7M | 154 | 16% | N/A |
Progenity Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-08-19 | $12.0M | Undisclosed | Article | |
| 2017-11-08 | $125.0M | B | Athyrium Capital Management | Article |